Dyne Therapeutics, Inc. (DYN)

Last Closing Price: 16.03 (2026-11-19)

Debt to Capital Ratio (Quarterly)

Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)

Dyne Therapeutics, Inc. (DYN) had Debt to Capital Ratio of 0.18 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-193.55M
--
--
$197.07M
$-197.07M
$3.52M
$-193.55M
$-193.55M
$-193.55M
$-193.55M
$-193.55M
$-193.55M
$-197.07M
$-196.66M
181.77M
181.77M
$-1.06
$-1.06
Balance Sheet Financials
$1.18B
$7.14M
$58.77M
$1.23B
$90.55M
$200.01M
$213.32M
$303.87M
$930.93M
$930.93M
$930.93M
187.33M
Cash Flow Statement Financials
$-452.70M
$-8.48M
$483.28M
$895.74M
$917.84M
$22.10M
$44.26M
--
--
Fundamental Metrics & Ratios
12.99
--
--
Debt to Capital Ratio
0.18
0.24
--
--
--
--
--
--
$-456.44M
--
--
--
--
--
--
--
-20.79%
-20.79%
-15.67%
-17.11%
$4.97
$-2.51
$-2.49